Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;188(1):86-100.
doi: 10.1111/bjh.16359. Epub 2019 Dec 11.

Twenty five years of UK trials in acute myeloid leukaemia: what have we learned?

Alan K Burnett  1 , Robert K Hills  2 , Nigel Russell  3
Affiliations
Review

Twenty five years of UK trials in acute myeloid leukaemia: what have we learned?

Alan K Burnett et al. Br J Haematol. 2020 Jan.
No abstract available

Keywords: acute leukaemia; acute myeloid leukaemia; acute promyelocytic leukaemia.

PubMed Disclaimer

References

    1. Amadori, S., Stasi, R., Martelli, A.M., Venditti, A., Meloni, G., Pane, F., Martinelli, G., Lunghi, M., Pagano, L., Cilloni, D., Rossetti, E., Di Raimondo, F., Fozza, C., Annino, L., Chiarini, F., Ricci, F., Ammatuna, E., La Sala, E., Fazi, P. & Vignetti, M. (2012) Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107). British Journal of Haematology, 156, 205-212.
    1. Burnett, A.K., Goldstone, A.H., Stevens, R.M., Hann, I.M., Rees, J.K., Gray, R.G. & Wheatley, K. (1998) Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. The Lancet, 351, 700-708.
    1. Burnett, A.K., Grimwade, D., Solomon, E., Wheatley, K. & Goldstone, A.H. (1999) Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. Blood, 93, 4131-4143.
    1. Burnett, A.K., Wheatley, K., Goldstone, A.H., Stevens, R.F., Hann, I.M., Rees, J.H. & Harrison, G. (2002) Medical Research Council Adult and Paediatric Working Parties. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. British Journal of Haematology, 118, 385-400.
    1. Burnett, A.K., Hills, R.K., Wheatley, K., Goldstone, A.H., Prentice, A.G. & Milligan, D. (2006) A Sensitive risk score for directing treatment in younger patients with AML. Blood, 108, 10a.

LinkOut - more resources